Paycom vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 85)

Paycom

LeaderManufacturing

Enterprise

Oklahoma City HCM software (NYSE: PAYC) at $1.88B 2024 revenue, 41% EBITDA margin; IWant AI command engine (2025), Beti self-service payroll for 37K+ clients competing with Paychex and UKG for mid-market HR platform.

AI VisibilityBeta
Overall Score
A85
Category Rank
#265 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
79
Gemini
89

About

Paycom Software, Inc. is an Oklahoma City, Oklahoma-based human capital management (HCM) software company — publicly traded on the New York Stock Exchange (NYSE: PAYC) as an S&P 500 component — providing a single-database HCM platform that manages payroll, talent acquisition, talent management, HR management, and time and labor for over 37,000 clients and 7 million+ employees through recurring subscription revenue of $1.88 billion in fiscal year 2024 with a 41% EBITDA margin and 90% annual client retention rate. Founded in 1998 by CEO Chad Richison (who funded the startup by selling his house and cashing out his 401k at age 27), Paycom was among the first companies to process payroll entirely online — pioneering cloud-based HR technology before SaaS was an established software delivery model. Paycom's single-database architecture (all HCM modules sharing one data layer, eliminating the file imports and reconciliation required by multi-vendor HR stacks) enables Beti®, the employee self-service payroll product where employees review and approve their own paychecks before processing — reducing payroll errors at the source rather than correcting them after the fact. In 2025, Paycom launched IWant™, a command-driven AI engine allowing users to access employee information through voice-to-text or typed natural language commands — named a Top HR Product of 2025 by HR Executive magazine.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

85
Overall Score
90
#265
Category Rank
#9
71
AI Consensus
60
stable
Trend
stable
85
ChatGPT
99
79
Perplexity
99
89
Gemini
83
88
Claude
96
79
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.